Download PDF

1. Company Snapshot

1.a. Company Description

The Pennant Group, Inc.provides healthcare services in the United States.It operates in two segments, Home Health and Hospice Services, and Senior Living Services.


The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support.As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming.


The Pennant Group, Inc.was incorporated in 2019 and is headquartered in Eagle, Idaho.

Show Full description

1.b. Last Insights on PNTG

The Pennant Group, Inc.'s recent performance was negatively driven by its Q4 earnings miss, with the company reporting $0.24 per share, below the consensus estimate of $0.25. This was likely due to higher medical care costs and operating expenses, which may have pressured the company's margins. Additionally, the company's recent acquisition of senior living communities in Idaho and Texas may have added to its expenses, weighing on its earnings. Furthermore, the company's guidance may have also been impacted by the ongoing challenges in the senior living and healthcare industries.

1.c. Company Highlights

2. The Pennant Group's Q3 2025 Earnings: A Strong Performance

The Pennant Group reported a robust third quarter 2025, with revenues reaching $229 million, a 26.8% increase from the prior year quarter. Adjusted EBITDA was $17.3 million, a 14.5% increase, and adjusted EPS was $0.30, a 15.4% increase. The actual EPS came in at $0.30, slightly beating estimates of $0.29. The company's financial performance was driven by its Home Health and Hospice segment, which saw revenue increase by 27.9% and adjusted EBITDA increase by 22.7%. As CFO Lynette Walbom noted, the company's strong balance sheet, with $30.2 million drawn on the revolving line of credit and $2.3 million in cash on hand at quarter end, provides a solid foundation for future growth.

Publication Date: Nov -19

📋 Highlights
  • Revenue Surge:: Q3 2025 revenue reached $229 million, a 26.8% increase ($48.4M) YoY.
  • EBITDA Growth:: Adjusted EBITDA rose 14.5% to $17.3 million ($2.2M increase) YoY.
  • Home Health & Hospice Outperformance:: Segment revenue grew 27.9% ($37.9M) with EBITDA up 22.7% ($5M).
  • Amedisys Acquisition Impact:: Added 54 locations with $189.3M TTM revenue for $146.5M purchase price.
  • Zion's Way Clinical Excellence:: Achieved 5-star ratings, 3.5% preventable hospitalizations (vs 9.9% national), and 34% EBITDA growth YoY.

Operational Highlights

The company's operational results were equally impressive, with Zion's Way, a key resource to communities across its geographic service area, achieving 5-star ratings for clinical quality and potentially preventable hospitalizations below 3.5%. Employee turnover decreased to 15%, and employee engagement was 93%, fueling 2025 financial performance with an 11% increase in revenue and a 34% increase in EBITDA. Lo-Har Senior Living also performed well, with consistent 100% occupancy and a 92% employee engagement score.

Acquisition and Integration

The company's recent acquisition of United Amedisys added 54 locations with combined trailing 12-month revenues of $189.3 million. The integration efforts are well underway, with a focus on identifying and elevating local leaders and implementing a shared services organization. EBITDA margin guidance for 2026 is expected to be between 9.5% and 11%, with an initial light contribution in the fourth quarter due to transition costs.

Valuation and Outlook

With a P/E Ratio of 33.59 and an EV/EBITDA of 23.13, the market is pricing in a certain level of growth. Analysts estimate next year's revenue growth at 24.0%, which is in line with the company's historical performance. The company's ROE is 9.94%, and ROIC is 5.1%, indicating a reasonable return on equity. The Net Debt / EBITDA ratio is 5.76, which may be a concern, but the company's strong cash flow generation should help mitigate this. Overall, the company's strong operational performance, coupled with its growth prospects, makes it an attractive investment opportunity.

3. NewsRoom

Card image cap

The Pennant Group, Inc. $PNTG Stake Boosted by Creative Planning

Dec -02

Card image cap

Geode Capital Management LLC Boosts Stock Position in The Pennant Group, Inc. $PNTG

Nov -29

Card image cap

Gold (XAU/USD) Price Forecast: Bull Pennant Tightens – $4,245 Breakout Key

Nov -25

Card image cap

The Pennant Group, Inc. (NASDAQ:PNTG) Receives Average Rating of “Hold” from Analysts

Nov -17

Card image cap

Does The Pennant Group (PNTG) Have the Potential to Rally 30.69% as Wall Street Analysts Expect?

Nov -13

Card image cap

The Pennant Group, Inc. (PNTG) Q3 2025 Earnings Call Transcript

Nov -06

Card image cap

The Pennant Group (PNTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Nov -06

Card image cap

The Pennant Group, Inc. (PNTG) Tops Q3 Earnings and Revenue Estimates

Nov -06

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.55%)

6. Segments

Home Health and Hospice

Expected Growth: 8%

The Pennant Group's Home Health and Hospice segment growth is driven by an aging population, increasing preference for home-based care, and the shift towards value-based care. Additionally, the company's strategic acquisitions, expansion into new markets, and focus on quality care delivery are contributing to its 8% growth.

Senior Living

Expected Growth: 10%

The Pennant Group's Senior Living segment growth is driven by increasing demand for age-friendly housing, rising healthcare expenditures, and an aging population. Additionally, the company's strategic acquisitions, operational efficiencies, and focus on high-quality care are contributing to its 10% growth rate.

7. Detailed Products

Home Health Services

The Pennant Group, Inc. provides home health services, including skilled nursing, physical therapy, occupational therapy, speech therapy, and medical social work, to patients in the comfort of their own homes.

Hospice Services

The company offers hospice services, including medical, emotional, and spiritual care, to patients with terminal illnesses, focusing on comfort and quality of life.

Home and Community-Based Services

The Pennant Group, Inc. provides home and community-based services, including personal care, adult day care, and case management, to support individuals with disabilities or chronic conditions.

Inpatient Services

The company operates inpatient facilities, providing 24/7 skilled nursing care, rehabilitation, and therapy services to patients who require intensive medical care.

8. The Pennant Group, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for The Pennant Group, Inc. is medium due to the presence of alternative healthcare providers and services.

Bargaining Power Of Customers

The bargaining power of customers for The Pennant Group, Inc. is low due to the lack of concentration of buyers and the high switching costs.

Bargaining Power Of Suppliers

The bargaining power of suppliers for The Pennant Group, Inc. is medium due to the moderate concentration of suppliers and the availability of substitutes.

Threat Of New Entrants

The threat of new entrants for The Pennant Group, Inc. is high due to the low barriers to entry and the attractiveness of the industry.

Intensity Of Rivalry

The intensity of rivalry for The Pennant Group, Inc. is high due to the high level of competition and the presence of many competitors in the industry.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 70.14%
Debt Cost 3.95%
Equity Weight 29.86%
Equity Cost 13.95%
WACC 6.93%
Leverage 234.88%

11. Quality Control: The Pennant Group, Inc. passed 2 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Healthcare Services Group

A-Score: 4.8/10

Value: 4.0

Growth: 2.9

Quality: 5.8

Yield: 2.0

Momentum: 9.5

Volatility: 4.7

1-Year Total Return ->

Stock-Card
U.S. Physical Therapy

A-Score: 4.7/10

Value: 3.2

Growth: 3.3

Quality: 4.9

Yield: 4.0

Momentum: 6.0

Volatility: 6.7

1-Year Total Return ->

Stock-Card
Pennant

A-Score: 3.8/10

Value: 3.1

Growth: 8.2

Quality: 3.9

Yield: 0.0

Momentum: 2.0

Volatility: 5.3

1-Year Total Return ->

Stock-Card
AirSculpt Technologies

A-Score: 3.7/10

Value: 4.6

Growth: 4.8

Quality: 2.5

Yield: 1.0

Momentum: 8.0

Volatility: 1.3

1-Year Total Return ->

Stock-Card
AMN Healthcare Services

A-Score: 3.4/10

Value: 9.2

Growth: 4.7

Quality: 3.0

Yield: 0.0

Momentum: 0.0

Volatility: 3.7

1-Year Total Return ->

Stock-Card
The Joint

A-Score: 3.2/10

Value: 3.3

Growth: 3.3

Quality: 4.9

Yield: 0.0

Momentum: 3.5

Volatility: 4.0

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

29.21$

Current Price

29.21$

Potential

-0.00%

Expected Cash-Flows